8-K: Omada Health Annual Meeting: Directors Elected, Auditor Ratified

Omada Health, Inc. held its 2026 Annual Meeting of Stockholders, where shareholders elected directors Sean Duffy and Trevor Fetter and ratified the appointment of Deloitte & Touche LLP as its independent auditor.

Summary

• Omada Health, Inc. conducted its 2026 Annual Meeting of Stockholders on June 16, 2026.
• The meeting's agenda included the election of Class I Directors and the ratification of the independent registered public accounting firm.
• Shareholders voted to elect Sean Duffy and Trevor Fetter as Class I Directors, with their terms extending until the 2029 annual meeting.
• The appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified by the stockholders.
• The record date for determining stockholders entitled to vote was April 20, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting routine corporate governance activities with strong shareholder support for established leadership and audit functions.

Positives

• Successful election of two Class I Directors, Sean Duffy and Trevor Fetter, indicating shareholder confidence in their leadership.
• Ratification of Deloitte & Touche LLP as the independent auditor, suggesting a smooth and accepted audit process.
• High number of votes in favor for both director elections and auditor ratification, demonstrating broad shareholder support.

Future Outlook

The filing does not contain specific forward-looking financial guidance. The future outlook is implicitly tied to the continued service of elected directors and the established auditor.

Management Comments

• Sean Duffy, Chief Executive Officer, signed the report on behalf of Omada Health, Inc.

Industry Context

StockSavvy.ai notes that the routine election of directors and ratification of auditors at an annual meeting are standard corporate governance procedures. This filing confirms the continuity of leadership and financial oversight for Omada Health.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Confirmation of board leadership and auditor provides stability and confidence in corporate governance.
• Employees: Continued leadership may imply stability in company direction and operations.
• Creditors: Ratification of auditor suggests ongoing commitment to financial transparency, which is important for creditworthiness.

Next Steps

• Sean Duffy and Trevor Fetter will serve as Class I Directors until the 2029 annual meeting of stockholders.
• Deloitte & Touche LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

Key Dates

Keywords

Omada Health, Annual Meeting, Stockholders, Directors Election, Independent Auditor, Deloitte & Touche LLP, Corporate Governance, SEC Filing